These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 3895752)

  • 1. [Myelography and headache].
    Hammer B
    Wien Med Wochenschr; 1985 Jun; 135(11):259-63. PubMed ID: 3895752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double blind study of the toxicity of intrathecal iopamidol and metrizamide in lumbar myelography.
    Vézina JL; Fox AJ
    J Can Assoc Radiol; 1984 Sep; 35(3):257-8. PubMed ID: 6501380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adverse reactions during ascending cervical myelography using iopamidol and metrizamide--a double-blind study].
    Bockenheimer S; Eichenlaub H
    Rontgenpraxis; 1986 May; 39(5):171-4. PubMed ID: 3523789
    [No Abstract]   [Full Text] [Related]  

  • 4. Iotrol, a new water-soluble non-ionic dimeric contrast medium for intrathecal use.
    Hammer B; Deisenhammer E
    Neuroradiology; 1985; 27(4):337-41. PubMed ID: 3900800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iopamidol and metrizamide for myelography: prospective double-blind clinical trial.
    Witwer G; Cacayorin ED; Bernstein AD; Hubballah MY; Yuan HA; Kieffer SA
    AJR Am J Roentgenol; 1984 Oct; 143(4):869-73. PubMed ID: 6382981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Side effects of 2 water-soluble contrast media used in myelography].
    Caillé JM
    Ann Radiol (Paris); 1983 Dec; 26(8 Pt 2):779-82. PubMed ID: 6689467
    [No Abstract]   [Full Text] [Related]  

  • 7. Iopamidol, a new non-ionic hydrosoluble contrast medium for neuroradiology.
    Hammer B; Lackner W
    Neuroradiology; 1980 Apr; 19(3):119-21. PubMed ID: 6991972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind clinical trial of iopamidol versus metrizamide for lumbosacral myelography.
    Drayer BP; Vassallo C; Sudilovsky A; Luther JS; Wilkins RH; Allen S; Bates M
    J Neurosurg; 1983 Apr; 58(4):531-7. PubMed ID: 6338167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized blind trial of iopamidol (Niopam) and Metrizamide (Amipaque) in lumber radiculography.
    McAllister VL; Hall K
    Neuroradiology; 1983; 24(4):217-8. PubMed ID: 6338415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between contrast medium dose and adverse effects in lumbar myelography.
    Wilmink JT; Lindeboom SF; Vencken LM; vd Burg W
    Diagn Imaging Clin Med; 1984; 53(4):208-14. PubMed ID: 6380885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iotrol versus metrizamide in lumbar myelography: a double-blind study.
    Malnor MD; Houston LW; Strother CM; Turski PA; Sackett JF; Boyer M
    Radiology; 1986 Mar; 158(3):845-7. PubMed ID: 3945762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iopamidol vs. metrizamide myelography: clinical comparison of side effects.
    Trevisan C; Malaguti C; Manfredini M; Tampieri D
    AJNR Am J Neuroradiol; 1983; 4(3):306-8. PubMed ID: 6410728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lumbar myelography with iohexol and metrizamide: a comparative multicenter prospective study.
    Kieffer SA; Binet EF; Davis DO; Gabrielsen TO; Kido DK; Latchaw RE; Turski PA; Shaw DD
    Radiology; 1984 Jun; 151(3):665-70. PubMed ID: 6371890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual evoked response changes following intrathecal injection of water-soluble contrast media: a possible method of assessing neurotoxicity and a comparison of metrizamide and iopamidol.
    Broadbridge AT; Bayliss SG; Firth R; Farrell G
    Clin Radiol; 1984 Sep; 35(5):371-3. PubMed ID: 6547888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iopamidol and metrizamide in cervical myelography: side effects, EEG, and CSF changes.
    Moschini L; Manara O; Bonaldi G; Cassinari V; Quilici N; Belloni G
    AJNR Am J Neuroradiol; 1983; 4(3):848-50. PubMed ID: 6410870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iotrol, a new myelographic agent: 2. Comparative electroencephalographic evaluation by spectrum analysis.
    Sovak M; Ranganathan R; Kerber CW; Bickford R; Alksne JF
    AJNR Am J Neuroradiol; 1983; 4(3):319-22. PubMed ID: 6410733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iopamidol for myelography. A clinical trial with a new non-ionic contrast medium.
    Peeters F; van Dongen K; Hekster R; Hoogland P; Thijssen H; Tjian T; Wilmink J; Althuisius H
    Diagn Imaging; 1983; 52(6):313-5. PubMed ID: 6357678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical comparison of metrizamide and iopamidol for myelography.
    Turski PA; Sackett JF; Gentry LR; Strother CM; Matozzi F
    AJNR Am J Neuroradiol; 1983; 4(3):309-11. PubMed ID: 6410729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iopamidol vs metrizamide: a double blind study for cervical myelography.
    Drayer BP; Warner MA; Sudilovsky A; Luther J; Wilkins R; Allen S; Bates M
    Neuroradiology; 1982; 24(2):77-84. PubMed ID: 7177374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New non-ionic contrast media for myelography].
    Sviridov NK
    Med Radiol (Mosk); 1984 Feb; 29(2):63-8. PubMed ID: 6366425
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.